Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study

BACKGROUND: Rapid deployment of COVID-19 vaccines is challenging for safety surveillance, especially on adverse events of special interest (AESIs) that were not identified during the pre-licensure studies. This study evaluated the risk of hospitalisations for predefined diagnoses among the vaccinate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ab Rahman, Norazida, Lim, Ming Tsuey, Lee, Fei Yee, Lee, Sing Chet, Ramli, Azuana, Saharudin, Siti Nurhafizah, King, Teck Long, Anak Jam, Emelyne Bani, Ayub, Nor Aliya, Sevalingam, Raj Kumar, Bahari, Rashidah, Ibrahim, Nor Nadziroh, Mahmud, Fatihah, Sivasampu, Sheamini, Peariasamy, Kalaiarasu M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163997/
https://www.ncbi.nlm.nih.gov/pubmed/35667917
http://dx.doi.org/10.1016/j.vaccine.2022.05.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163997/
https://www.ncbi.nlm.nih.gov/pubmed/35667917
http://dx.doi.org/10.1016/j.vaccine.2022.05.075

Ejemplares similares